Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Celgene Corp (NQ: CELG)
124.91 USD  +1.43 (+1.16%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Celgene Corp
 
< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
Stocks in Focus (Celldex Therapeutics, BioMarin Pharmaceutical Inc, Celgene Corporation, Computer Sciences Corporation)
May 17, 2013
Austin, TX -- (SBWIRE) -- 05/17/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
NASDAQ 100 Mid-day Update: Higher Top Performers: CSCO, NTAP, FFIV
May 16, 2013
New York, May 16th (TradersHuddle.com) - The NASDAQ 100 Index is higher trading at 2996.05, which represents 0.47% versus its previous close. The index is mixed for the session with slightly less than... Read More
from TradersHuddle.com
Options Players Wage on Celgene Corporation
May 16, 2013
NEW YORK (AVAFIN) -- Celgene Corporation witnessed a record number of call and put ... Read More
from AVAFIN
(ENDP) Endo Health Solutions Sees FDA Setback on Opana ER
May 15, 2013
Endo Health Solutions Inc. (ENDP) recently suffered a setback with the US Food and Drug... Visit StockBlogHub to view complete post. Read More
category Lannett Company Inc , CELG , Cubist Pharmaceuticals Inc/ , and 9 more.
from Stock Blog Hub
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
Below are the top biotechnology stocks on the NASDAQ in terms of earnings estimate for the next quarter. Biogen Idec (NASDAQ: BIIB ) is estimated to post earnings of $2.07 per share in the September... Read More
category Benzinga , Highest EPS Estimates , CELG , and 6 more.
from Latest Articles from Benzinga.com
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
Jim Cramer often advocates themes in the market. These are big picture ideas that he believes will lift the fortunes of companies and by proxy their stocks. Following are 5 themes that he likes right... Read More
category Regeneron Pharmaceuticals Inc , EOG Resources Inc , ENSCO International Incorporated , and 14 more.
from CNBC.com News
Gene Therapy Company Bluebirdbio (BLUE) Files $86M IPO
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8338375 for the full story. Read More
from StreetInsider.com News Articles
Critical Alerts For Yahoo!, Celgene, Brinker International, Qlik Technologies, and Beam Released By InvestorsObserver
May 13, 2013
from PR Newswire
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Strategy Behind Our Success, We Get in Early: MDLZ, YHOO, F and CELG
May 11, 2013
from Marketwired News Releases
NASDAQ Gainers Watch List: Amarin Corporation Plc (NASDAQ:AMRN), Unilife Corporation (NASDAQ:UNIS), and Celgene Corporation (NASDAQ:CELG) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 10, 2013
New York, NY -- (SBWIRE) -- 05/10/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Amarin Corporation plc (NASDAQ:AMRN), Unilife Corporation (NASDAQ:UNIS), and Celgene... Read More
from SBWire - Latest Press Releases
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
May 10, 2013
from Business Wire News Releases
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
NeoStem CEO's Letter to Shareholders
May 09, 2013
from GlobeNewswire News Releases
Why I stopped using stop loss orders
May 09, 2013
A big problem with stop losses is that you give up control of your sell order. During volatile markets, that can cost you money. But there is an alternative, writes Michael Sincere. Read More
category VRX , Opinion , Commentary , and 12 more.
from MarketWatch
Santarus, Inc. (NASDAQ:SNTS), Celgene Corporation (NASDAQ:CELG), and Express Scripts Holding Company (NASDAQ:ESRX) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 07, 2013
New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Santarus, Inc. (NASDAQ:SNTS), Celgene Corporation (NASDAQ:CELG), and Express Scripts... Read More
from SBWire - Latest Press Releases
Celgene’s Revlimid Approaches FDA Decision For MCL Indication
May 07, 2013
Celgene Corporation (NASDAQ: CELG) remains just under its 52-week high of $128.52 per share as the market continues to reflect the company’s financial and developmental success halfway throughout the... Read More
category CELG , Bio/Wire
from Bio-Wire.Com
Key to Success, How to Profit: CLF, USB, CELG and CMCSA
May 07, 2013
from Marketwired News Releases
UPDATE: Celgene's Says Apremilast Achieves Statistical Significant for Primary, Major Secondary Endpoints in Fourth Pivotal Phase III Study
May 06, 2013
Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG ) today announced that statistical significance was achieved for the primary endpoint of ACR 20 at week 16 for patients... Read More
category Benzinga , CELG , News , and 1 more.
from Latest Articles from Benzinga.com
Celgene (CELG) Unit Achieves Statistical Significance in PALACE 4
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8308093 for the full story. Read More
from StreetInsider.com News Articles
Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients with Psoriatic Arthritis
May 06, 2013
from Business Wire News Releases
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last... Read More
category Prime Content , AEGR , REGN , and 5 more.
from Bio-Wire.Com
IBB, AMGN, CELG, ALXN: ETF Inflow Alert
May 06, 2013
Symbols mentioned in this story: IBB, AMGN, CELG, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Minyanville's T3 Morning Market Call: Time to Take Profits or Stay the Course?
May 06, 2013
Banks have been a bit lethargic while tech continues to be filled with opportunity. Read More
category MSFT , CELG , NFLX , and 1 more.
from Minyanville Headlines
Concert Pharma Reports Strategic Collaboration with Celgene
May 06, 2013
Concert Pharmaceuticals, Inc. today announced that it has entered into a strategic collaboration with Celgene Corporation (NASDAQ: CELG ) directed towards deuterium-modified compounds targeting cancer... Read More
category Benzinga , CELG , News
from Latest Articles from Benzinga.com
Top Fund Buys Focus On Defensive Stocks, Housing
May 02, 2013
April notched another month of gains for the stock market. That's four straight months so far this year. But this market rally is getting long in the tooth and top fund managers have been cautious in... Read More
category Mutual Funds
from Investor's Business Daily - Investing RSS
Before the Crowd, How We Found UTX, CELG, NWSA and MDLZ
May 02, 2013
from Marketwired News Releases
Illumina and Other Bargain Biotech Stocks Worth a Look Now
May 01, 2013
The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list... Read More
category SHPG , amgen , Benzinga , and 31 more.
from Latest Articles from Benzinga.com
NASDAQ Decliners Watch List: Celgene Corporation (NASDAQ:CELG) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Added to Equity Profile Report's NASDAQ Decliners Watch List.
April 30, 2013
Wilmington, DE -- (SBWIRE) -- 04/30/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Celgene Corporation (NASDAQ:CELG) and Vertex Pharmaceuticals Incorporated... Read More
from SBWire - Latest Press Releases
Uptrend Call Working As Celgene Stock Rises 51.6% (CELG)
April 30, 2013
from Comtex SmarTrend® News Briefs
< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here